To investigate the involvement of aberrant PTEN-PI3K/AKT/mTOR signaling cascade in HBV-associated liver cancer, we studied cancer development of liver-specific HBV transgenic and Pten deletion mice. The gene discussed is PTEN; the disease is cancer.